Glycosyn Pharmaceuticals Inc., New Concept Therapeutics Inc. deal

Glycosyn will purchase 19 percent of the outstanding

Read the full 86 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE